This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Rights and permissions
About this article
Cite this article
Oral Sessions. Bone Marrow Transplant 49 (Suppl 1), S6–S88 (2014). https://doi.org/10.1038/bmt.2014.43
Published:
Issue Date:
DOI: https://doi.org/10.1038/bmt.2014.43
This article is cited by
-
Efficacy and safety of mesenchymal stromal cells for the prophylaxis of chronic graft-versus-host disease after allogeneic hematopoietic stem cell transplantation: a meta-analysis of randomized controlled trials
Annals of Hematology (2018)
-
Allogeneic transplantation for CML in the TKI era: striking the right balance
Nature Reviews Clinical Oncology (2016)